ACCORD HEALTHCARE, INC. Recalls

13 recalls on record in the United States

drugs: 13
drugs Class II
2026-07-08

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Table

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), package

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-co

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-c

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packa

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-coun

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-c

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-c

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packa

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), package

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-c

Subpotent Drug

View recall details →

drugs Class II
2026-09-02

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-

Subpotent Drug

View recall details →